Radioiodine as an adjunct to the surgical treatment of medullary thyroid carcinoma

J Clin Endocrinol Metab. 1980 May;50(5):967-8. doi: 10.1210/jcem-50-5-967.

Abstract

After total thyroidectomy for medullary thyroid carcinoma, a 50-yr-old male was found to have decreased but still abnormally elevated plasma calcitonin levels. A thyroid scan with 131I revealed remaining thyroid tissue primarily in the form of a thyroglossal duct remnant. Two courses of 131I treatment of 30 and 150 mCi, respectively, produced a gradual decrease in plasma calcitonin. This study demonstrates that carefully selected patients may benefit from the use of 131I treatment as an adjunct to surgery in medullary thyroid carcinoma.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Calcitonin / blood
  • Humans
  • Iodine Radioisotopes / therapeutic use*
  • Male
  • Middle Aged
  • Pentagastrin
  • Thyroid Neoplasms / blood
  • Thyroid Neoplasms / therapy*
  • Thyroidectomy

Substances

  • Iodine Radioisotopes
  • Calcitonin
  • Pentagastrin